Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06739447 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hospital Based Continuous Patient Monitoring System

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Sep 1, 2026 to Nov 1, 2026
    • Secondary endpoints: details revised at 3 of 3 entries
    • Collaborators: details revised at 1 of 7 entries
    • Eligibility criteria expanded, about 4 words
  2. Start date: Jun 1, 2026 to Sep 1, 2026
    • Collaborators: 5 to 7
    v9
  3. Start date: Apr 30, 2026 to Jun 1, 2026
    • Study completion date: Jan 2030 to Jan 30, 2030
    v8
  4. Start date: Mar 15, 2026 to Apr 30, 2026v7
  5. Start date: Jan 2026 to Mar 15, 2026v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Dec 2030 to Nov 30, 2029v5 Show 6 more changesShow less
    • Start date: Oct 2025 to Jan 2026
    • Primary endpoints: 4 to 3
    • Study completion date: Feb 2031 to Jan 2030
    • Secondary endpoints: 4 to 3
    • Collaborators: 4 to 5
    • Study description shortened, about 2 words
  2. Start date: Jul 2025 to Oct 2025v4
  3. Start date: May 2025 to Jul 2025v3
  4. Start date: Mar 2025 to May 2025v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In Ghana, and many other low and middle income countries in Africa, manual vital signs monitoring is the prevalent mode of vital signs monitoring because continuous bedside monitors are non-functional. This lack of continuous vital signs monitoring may result in missed opportunities to catch physiologic deterioration. The investigators propose to develop a dashboard that is based on the Garmin Venu 3, a consumer wearable device that reliably measures heart rate, SPO2, and respiratory rate, as an alternative to bedside monitors in hospitals in Ghana.
Trial Details
NCT Number NCT06739447
Lead Sponsor University of Alabama at Birmingham
Collaborators: Northwestern University, University of Chicago, Ann & Robert H Lurie Children's Hospital of Chicago, University of Ghana, Loyola University, Fogarty International Center of the National Institute of Health, National Institutes of Health (NIH)
Conditions
(from sponsor)		 Trauma, Appendectomy, Pediatric ALL, Vital Signs Monitoring
Related terms Precursor Cell Lymphoblastic Leukemia-Lymphoma, Wounds and Injuries
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov